LACHEN, Switzerland, Nov 21 (Bernama-BUSINESS WIRE) -- 2017: Octapharma is pleased to announce the completion of a charitable donation of 30.5 million international units of its human cell-line derived recombinant factor VIII product, Nuwiq®, in collaboration with Project SHARE, North Andover, Massachusetts (USA).
This press release features multimedia. View the full release here: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=51718944&lang=en Up to 75% of the world's estimated 400,000 people with haemophilia have little or no access to treatment that resolves life- and limb-threatening bleeds, and enables surgery and rehabilitation. A humanitarian program, Project SHARE facilitates the donation of blood-clotting factor products for the treatment of people with haemophilia in need of factor replacement therapy in countries where these medicines are scarce or still unavailable. Over the last nine months, donations of Nuwiq® have been reaching seriously ill people in need in 16 countries: Armenia, Bahamas, Bangladesh, Barbados, Cambodia, Egypt, Ethiopia, Fiji, Kenya, Honduras, Myanmar, Nepal, Nicaragua, Philippines, Romania and Venezuela. mrem.bernama.com/viewsm.php?idm=30612
0 Comments
Leave a Reply. |
Archives
April 2023
Categories |